Product Information
DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY is a generic product labeled by Cipla USA Inc., priced at $29.4355 per ML under NDC 69097050327. Its NADAC has been published 323 times since Jul 29, 2020.
FDA first approved this application on May 20, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/mL
Manufacturer
Cipla USA Inc.NDC
69097050327
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
DIHYDROERGOTAMINE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212907FDA Approved
5/20/2020
TE Code
AB
On Market Since
5/23/2020
Pharmacological Classes
Price Statistics
The NADAC for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY has been published 323 times since Jul 29, 2020, and over the history we have for it it has declined 91.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $29.4355 per ML |
|---|---|
| All-time high | $365.0048 (Aug 12, 2020) |
| All-time low | $29.4355 (Sep 23, 2026) |
| 52-week high | $35.4287 |
| 52-week low | $29.4355 |
| Median price | $111.5162 |
| Average price | $100.0639 |
| Largest weekly change | +106.2% (Apr 17, 2024) |
| Weeks tracked | 323 |
| Tracking since | Jul 29, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dihydroergotamine Mesylate Nasal market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dihydroergotamine Mesylate Nasal market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Ergotamine Derivative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY, manufactured by Cipla USA Inc., is $29.4355 per ML (NDC 69097050327), effective Sep 30, 2026.
How has the price of DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY has declined 91.9%. It has been tracked across 323 weekly CMS publications since Jul 29, 2020.
What are the highest and lowest recorded NADAC prices for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY?
Since Jul 29, 2020, the NADAC for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY has ranged from a low of $29.4355 (Sep 23, 2026) to a high of $365.0048 (Aug 12, 2020), with a median of $111.5162 per ML.
Are there cheaper alternatives to DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY?
DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY (NDC 69097050327) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.